Albemarle Corporation

DB:AMC Stock Report

Market Cap: €16.6b

Albemarle Valuation

Is AMC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of AMC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: AMC (€142.1) is trading above our estimate of future cash flow value (€82.33)

Significantly Below Future Cash Flow Value: AMC is trading above our estimate of future cash flow value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AMC?

Key metric: As AMC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for AMC. This is calculated by dividing AMC's market cap by their current revenue.
What is AMC's PS Ratio?
PS Ratio3.8x
SalesUS$5.14b
Market CapUS$19.60b

Price to Sales Ratio vs Peers

How does AMC's PS Ratio compare to its peers?

The above table shows the PS ratio for AMC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1x
1COV Covestro
0.8x2.51%€11.3b
SY1 Symrise
2.1x4.09%€10.4b
EVK Evonik Industries
0.5x2.14%€7.2b
WCH Wacker Chemie
0.7x2.10%€4.0b
AMC Albemarle
3.8x8.36%€19.6b

Price-To-Sales vs Peers: AMC is expensive based on its Price-To-Sales Ratio (3.8x) compared to the peer average (1x).

Historical Price to Sales Ratio

Historical Price to Sales Ratio compares a stock's price to its sales over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Sales Ratio vs Industry

How does AMC's PS Ratio compare vs other companies in the DE Chemicals Industry?

2 CompaniesPrice / SalesEstimated GrowthMarket Cap
7M8 EcoRub
0.07xn/aUS$57.24m
B7Y Byotrol
0.04xn/aUS$246.97k
No more companies available in this PS range
AMC 3.8xIndustry Avg. 1.0xNo. of Companies3PS00.40.81.21.62+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: AMC is expensive based on its Price-To-Sales Ratio (3.8x) compared to the European Chemicals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is AMC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AMC PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio3.8x
Fair PS Ratio0.6x

Price-To-Sales vs Fair Ratio: AMC is expensive based on its Price-To-Sales Ratio (3.8x) compared to the estimated Fair Price-To-Sales Ratio (0.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AMC forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€142.10
€155.74
+9.60%
20.16%€194.37€70.38n/a22
Feb ’27€140.24
€144.50
+3.04%
23.48%€192.53€69.71n/a23
Jan ’27€123.24
€106.62
-13.48%
26.66%€170.82€64.06n/a23
Dec ’26€111.40
€91.19
-18.14%
26.51%€173.54€50.33n/a23
Nov ’26€85.46
€82.74
-3.18%
30.13%€171.58€49.76n/a23
Oct ’26€71.61
€73.75
+2.98%
32.91%€170.22€49.36n/a22
Sep ’26€73.22
€73.07
-0.21%
33.81%€170.98€49.58n/a22
Aug ’26€58.02
€72.14
+24.34%
35.78%€172.72€50.09n/a23
Jul ’26€52.93
€69.53
+31.36%
36.35%€169.80€49.24n/a25
Jun ’26€49.00
€72.59
+48.15%
36.29%€176.16€51.09n/a25
May ’26€51.23
€74.62
+45.65%
34.39%€177.14€53.14n/a26
Apr ’26€66.21
€93.59
+41.36%
30.65%€207.86€62.82n/a27
Mar ’26€74.39
€98.40
+32.27%
30.88%€216.95€65.57n/a27
Feb ’26€82.10
€111.13
+35.36%
28.15%€217.06€70.42€140.2427
Jan ’26€84.30
€113.54
+34.68%
28.43%€217.01€70.41€123.2426
Dec ’25€101.84
€109.87
+7.88%
29.29%€212.36€68.90€111.4026
Nov ’25€88.09
€105.09
+19.30%
31.17%€208.01€67.49€85.4626
Oct ’25€84.89
€100.29
+18.15%
32.39%€201.51€65.38€71.6126
Sep ’25€81.25
€100.40
+23.57%
32.29%€201.17€65.27€73.2226
Aug ’25€89.37
€117.51
+31.49%
26.95%€208.51€75.06€58.0225
Jul ’25€89.83
€138.53
+54.21%
24.95%€256.60€75.58€52.9324
Jun ’25€111.00
€142.07
+27.99%
24.29%€254.62€75.00€49.0025
May ’25€113.02
€143.42
+26.90%
24.13%€258.80€76.23€51.2327
Apr ’25€121.28
€138.41
+14.13%
25.09%€253.72€74.73€66.2127
Mar ’25€131.60
€140.60
+6.84%
26.59%€276.84€83.05€74.3927
Feb ’25€105.30
€149.38
+41.87%
25.23%€276.00€82.80€82.1027
€157.42
Fair Value
9.7% undervalued intrinsic discount
22
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/17 17:50
End of Day Share Price 2026/02/17 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Albemarle Corporation is covered by 36 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
William SeleskyArgus Research Company
Benjamin KalloBaird
Andres Castanos-MollorBerenberg